IM Cannabis Corp. (IMCC) Stock Analysis
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
What IM Cannabis Corp. does
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Key metrics
ETFs linked to IMCC
Broad-market and Healthcare sector ETFs an investor holding IM Cannabis Corp. is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how IMCC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze IMCC in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for IM Cannabis Corp.?
- IM Cannabis Corp. trades under the ticker IMCC on NASDAQ.
- Which exchange is IMCC listed on?
- IMCC is listed on NASDAQ.
- What sector does IM Cannabis Corp. operate in?
- IM Cannabis Corp. is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
- How can PortView help analyze IMCC in a portfolio?
- PortView shows IMCC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.